| Identification | Back Directory | [Name]
(13(14)-DiHDPA | [CAS]
1345275-24-2 | [Synonyms]
(13(14)-DiHDPA
13,14-dihydroxy-4(Z),7(Z),10(Z),16(Z),19(Z)-docosapentaenoic acid | [Molecular Formula]
C22H34O4 | [MOL File]
1345275-24-2.mol | [Molecular Weight]
362.5 |
| Chemical Properties | Back Directory | [Boiling point ]
537.8±50.0 °C(Predicted) | [density ]
1.035±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMF: 50 mg/ml; DMSO: 50 mg/ml; Ethanol: 50 mg/ml; PBS (pH 7.2): 0.25 mg/ml | [pka]
4.58±0.10(Predicted) |
| Hazard Information | Back Directory | [Description]
(±)13(14)-DiHDPA is a metabolite of docosahexaenoic acid (DHA; ) that is produced via oxidation by cytochrome P450 epoxygenases. Epoxygenase metabolites of DHA, including (±)13(14)-DiHDPA, are reported to inhibit angiogenesis, tumor growth, and metastasis. | [Uses]
(±)13(14)-DiHDPA ((±)13,14-DiHDPE) a metabolite of Docosahexaenoic acid (DHA; HY-B2167) by P450 (CYP) metabolic pathways[1]. | [Definition]
ChEBI: 13,14-DiHDPE is a very long-chain fatty acid. | [storage]
Store at -20°C | [References]
[1] Susanna L Lundstr?m, et al. Lipid mediator serum profiles in asthmatics significantly shift following dietary supplementation with omega-3 fatty acids. Mol Nutr Food Res. 2013 Aug;57(8):1378-89. DOI:10.1002/mnfr.201200827 |
|
| Company Name: |
Alfa Chemistry
|
| Tel: |
1-516-6625404 |
| Website: |
https://www.alfa-chemistry.com |
| Company Name: |
amyjet
|
| Tel: |
4006800868;027-59626688 18371453821;18771149750 |
| Website: |
http://www.amyjet.com/ |
| Company Name: |
Enzo Biochem Inc
|
| Tel: |
Enzo Biochem Inc. 13797054060 |
| Website: |
www.enzo.com |
|